Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02519790 · ClinicalTrials.gov registry record

Optimizing Medication Management for Mothers With Depression

A clinical trial, sponsored by Northwestern University.

Completed
Registry status
88
Enrollment target

NCT02519790 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 88 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02519790 has completed, sponsored by Northwestern University.

COMPLETED
Registry status
88 participants
Enrollment target

Study Summary

The purpose of this study is to explore the way the antidepressant concentration (amount of medication) in the blood changes due to the physiological changes in the body (i.e., changes in metabolism, hormones and body fluid) during pregnancy and postpartum and the impact of genetic factors on the degree of these changes. Changes in antidepressant concentration are important to monitor, as decreases in antidepressant concentration may lead to less than therapeutic drug levels, which may cause an increase in mood symptoms or recurrence of depressive episodes. Increases in antidepressant concentration have the potential to lead to increased side effects. The study team is hoping to better understand the course of these changes across pregnancy and postpartum and how an individual's genetic makeup impacts these changes with the goal of developing guidelines to optimize antidepressant treatment of pregnant women.

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2016-08
Est. Completion 2021-06-30

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT02519790

The ClinicalTrials.gov registry entry for NCT02519790 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02519790 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02519790 about?

NCT02519790 is a clinical study titled "Optimizing Medication Management for Mothers With Depression". The purpose of this study is to explore the way the antidepressant concentration (amount of medication) in the blood changes due to the physiological changes in the body (i.e., changes in metabolism, hormones and body fluid) during pregnancy and postpartum and the impact of genetic factors on the de...

What is the current status of trial NCT02519790?

This trial is currently completed. The enrollment target is 88 participants. The study started on 2016-08. Estimated completion is 2021-06-30.

Who is sponsoring clinical trial NCT02519790?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.